MUCINEX

Mucinex Adverse Events Reported to the FDA Over Time

How are Mucinex adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Mucinex, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Mucinex is flagged as the suspect drug causing the adverse event.

Most Common Mucinex Adverse Events Reported to the FDA

What are the most common Mucinex adverse events reported to the FDA?

Completed Suicide	1694 (5.12%)
Drug Toxicity	859 (2.59%)
Cardiac Arrest	580 (1.75%)
Death	534 (1.61%)
Cardio-respiratory Arrest	507 (1.53%)
Respiratory Arrest	504 (1.52%)
Overdose	488 (1.47%)
Dizziness	376 (1.14%)
Intentional Drug Misuse	359 (1.08%)
Blood Pressure Increased	357 (1.08%)
Vomiting	357 (1.08%)
	Show More
Drug Abuse	346 (1.04%)
Intentional Overdose	314 (.95%)
Dyspnoea	301 (.91%)
Nausea	282 (.85%)
Loss Of Consciousness	273 (.82%)
Heart Rate Increased	270 (.82%)
Convulsion	261 (.79%)
Somnolence	258 (.78%)
Headache	248 (.75%)
Insomnia	248 (.75%)
Drug Ineffective	232 (.7%)
Tachycardia	211 (.64%)
Multiple Drug Overdose	210 (.63%)
Hypertension	202 (.61%)
Drug Interaction	198 (.6%)
Agitation	197 (.59%)
Hallucination	192 (.58%)
Hypotension	192 (.58%)
Suicide Attempt	191 (.58%)
Feeling Abnormal	187 (.56%)
Poisoning	186 (.56%)
Epistaxis	183 (.55%)
Incorrect Drug Administration Durat...	179 (.54%)
Drug Dependence	170 (.51%)
Confusional State	167 (.5%)
Tremor	167 (.5%)
Accidental Overdose	166 (.5%)
Multiple Drug Overdose Intentional	165 (.5%)
Diarrhoea	159 (.48%)
Medication Error	156 (.47%)
Palpitations	154 (.47%)
Incorrect Dose Administered	150 (.45%)
Anxiety	141 (.43%)
Coma	131 (.4%)
Hypersensitivity	130 (.39%)
Fatigue	129 (.39%)
Pyrexia	127 (.38%)
Pulmonary Oedema	125 (.38%)
Asthenia	124 (.37%)
Mydriasis	124 (.37%)
Dysarthria	120 (.36%)
Unresponsive To Stimuli	117 (.35%)
Chest Pain	115 (.35%)
Disorientation	114 (.34%)
Hyperhidrosis	112 (.34%)
Malaise	112 (.34%)
Lethargy	111 (.34%)
Urticaria	107 (.32%)
Condition Aggravated	101 (.31%)
Pruritus	101 (.31%)
Rash	99 (.3%)
Aggression	97 (.29%)
Serotonin Syndrome	95 (.29%)
Fall	94 (.28%)
Abnormal Behaviour	93 (.28%)
Depression	92 (.28%)
Off Label Use	89 (.27%)
Aspartate Aminotransferase Increase...	86 (.26%)
Alanine Aminotransferase Increased	84 (.25%)
Vision Blurred	84 (.25%)
Wrong Drug Administered	84 (.25%)
Abdominal Pain Upper	83 (.25%)
Dehydration	82 (.25%)
Delirium	82 (.25%)
Psychotic Disorder	82 (.25%)
Accidental Drug Intake By Child	81 (.24%)
Drug Screen Positive	81 (.24%)
Pneumonia	80 (.24%)
Cough	79 (.24%)
Suicidal Ideation	77 (.23%)
Rhabdomyolysis	76 (.23%)
Haemoptysis	75 (.23%)
Pain	75 (.23%)
Cardiac Disorder	74 (.22%)
Drug Hypersensitivity	74 (.22%)
Nervousness	74 (.22%)
Syncope	73 (.22%)
Wrong Technique In Drug Usage Proce...	72 (.22%)
Flushing	71 (.21%)
Hallucination, Visual	71 (.21%)
Oedema Peripheral	70 (.21%)
Pulmonary Congestion	70 (.21%)
Swelling Face	70 (.21%)
Disturbance In Attention	69 (.21%)
Toxic Anterior Segment Syndrome	69 (.21%)
Drug Exposure During Pregnancy	68 (.21%)
Blood Creatine Phosphokinase Increa...	67 (.2%)
Drug Abuser	67 (.2%)
Depressed Level Of Consciousness	66 (.2%)
Anosmia	65 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Mucinex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mucinex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Mucinex

What are the most common Mucinex adverse events reported to the FDA?

Medication Errors	2372 (7.16%)
Neurological	2275 (6.87%)
Suicidal And Self-injurious Behavio...	2016 (6.09%)
Cardiac Arrhythmias	1848 (5.58%)
Respiratory	1488 (4.49%)
Chemical Injury And Poisoning	1221 (3.69%)
Cardiac And Vascular Investigations	1082 (3.27%)
Psychiatric	1073 (3.24%)
Gastrointestinal Signs	972 (2.94%)
Epidermal And Dermal Conditions	687 (2.07%)
Fatal Outcomes	669 (2.02%)
	Show More
Therapeutic And Nontherapeutic Effe...	620 (1.87%)
Anxiety Disorders	514 (1.55%)
Disturbances In Thinking	495 (1.49%)
Infections - Pathogen Unspecified	454 (1.37%)
Injuries	398 (1.2%)
Upper Respiratory Tract Disorders	387 (1.17%)
Seizures	378 (1.14%)
Movement Disorders	366 (1.11%)
Deliria	364 (1.1%)
Lower Respiratory Tract Disorders	339 (1.02%)
Cardiac Disorder Signs	328 (.99%)
Sleep Disorders	328 (.99%)
Hepatic And Hepatobiliary	310 (.94%)
Allergic Conditions	290 (.88%)
Muscle	287 (.87%)
Hematology Investigations	286 (.86%)
Metabolic, Nutritional And Blood Ga...	278 (.84%)
Headaches	266 (.8%)
Hepatobiliary	266 (.8%)
Decreased And Nonspecific Blood Pre...	258 (.78%)
Vascular Hypertensive	227 (.69%)
Toxicology And Therapeutic Drug Mon...	222 (.67%)
Ocular Neuromuscular	218 (.66%)
Gastrointestinal Motility And Defec...	212 (.64%)
Mental Impairment	209 (.63%)
Lifestyle Issues	203 (.61%)
Vision	198 (.6%)
Mood Disorders	197 (.59%)
Physical Examination Topics	188 (.57%)
Renal Disorders	181 (.55%)
Electrolyte And Fluid Balance Condi...	173 (.52%)
Neuromuscular	172 (.52%)
Body Temperature Conditions	162 (.49%)
Water, Electrolyte And Mineral	157 (.47%)
Central Nervous System Vascular	149 (.45%)
Procedural And Device Related Injur...	146 (.44%)
Depressed Mood Disorders	145 (.44%)
Personality Disorders	140 (.42%)
Musculoskeletal And Connective Tiss...	139 (.42%)
Skin Appendage Conditions	139 (.42%)
Eye	138 (.42%)
Coronary Artery	137 (.41%)
Urinary Tract Signs	135 (.41%)
Oral Soft Tissue Conditions	133 (.4%)
Angiedema And Urticaria	127 (.38%)
Vascular	125 (.38%)
Therapeutic Procedures And Supporti...	122 (.37%)
Enzyme	120 (.36%)
Psychiatric And Behavioural Symptom...	116 (.35%)
Appetite And General Nutritional	115 (.35%)
Cranial Nerve Disorders	104 (.31%)
Bronchial Disorders	103 (.31%)
Ocular Infections, Irritations And ...	102 (.31%)
Renal And Urinary Tract Investigati...	101 (.31%)
Gastrointestinal Hemorrhages	95 (.29%)
Schizophrenia And Other Psychotic	95 (.29%)
Acid-base	94 (.28%)
Tongue Conditions	90 (.27%)
Encephalopathies	86 (.26%)
Product Quality Issues	86 (.26%)
Changes In Physical Activity	85 (.26%)
Heart Failures	84 (.25%)
Bacterial Infectious	68 (.21%)
Increased Intracranial Pressure And...	67 (.2%)
Legal Issues	67 (.2%)
Myocardial	65 (.2%)
Joint	62 (.19%)
Inner Ear And Viiith Cranial Nerve	59 (.18%)
White Blood Cell	58 (.18%)
Viral Infectious	56 (.17%)
Salivary Gland Conditions	55 (.17%)
Gastrointestinal Inflammatory Condi...	54 (.16%)
Skin Vascular Abnormalities	53 (.16%)
Aural	51 (.15%)
Bone And Joint Injuries	49 (.15%)
Vascular Hemorrhagic	45 (.14%)
Administration Site Reactions	44 (.13%)
Neonatal And Perinatal Conditions	43 (.13%)
Arteriosclerosis, Stenosis, Vascula...	42 (.13%)
Neurological, Special Senses And Ps...	41 (.12%)
Gastrointestinal Conditions	40 (.12%)
Communication Disorders	39 (.12%)
Glucose Metabolism Disorders	38 (.11%)
Tissue	38 (.11%)
Bone Disorders	37 (.11%)
Embolism And Thrombosis	32 (.1%)
Platelet	31 (.09%)
Pleural	31 (.09%)
Anemias Nonhemolytic And Marrow Dep...	28 (.08%)
Coagulopathies And Bleeding Diathes...	28 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Mucinex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Mucinex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.